I understand this. I was originally commenting on the post that you reposted from another person, which said "To summarize: Prurisol met the primary endpoint (2 pt reduction) in 35% of ALL patients who received a 200mg dose per day."
The "ALL" was even capitalized as if to stress this factor. However, there are 7 people who were assigned to the 200mg arm that are not included in this percentage; therefore, I believe this statement is false (unless the company reported these 7 individuals did not take 200mg per day, but I don't recall ever seeing/hearing this).
I'm not trying to be difficult, but with a small sample size, I believe we need to be careful with how we analyze the data.